MPG: A Promising Drug Target and Biomarker for Cancer (G4350)

Target Name: MPG

NCBI ID: G4350

Content of Review Report on MPG Target / Biomarker

MPG

MPG: A Promising Drug Target and Biomarker for Cancer

MPG (N-methylpurine-DNA glycosylase, MPG) is a gene that encodes a protein known as N-methylpurine-DNA glycosylase. This protein plays a crucial role in the regulation of DNA replication and is located on the X chromosome. It is a key enzyme in the DNA replication process, which is responsible for copying the genetic information from the mother to the offspring.

MPG is a potent inhibitor of DNA replication, and has been shown to be effective in preventing the development of cancer cells in animal models. It works by inhibiting the activity of the DNA replication complex, which includes the enzyme DNA polymerase. This inhibition leads to a reduction in the number of newly synthesized DNA strands, which can result in the death of the cancer cells.

MPG has also been shown to be a potential drug target in cancer. By inhibiting DNA replication, MPG can inhibit the growth and spread of cancer cells. This makes it an attractive target for cancer treatments, as it can be used to prevent the development of new cancerous tumors.

In addition to its potential as a drug target, MPG is also a potential biomarker for cancer. The expression of MPG has been shown to be elevated in various types of cancer, including breast, ovarian, and prostate cancer. This suggests that MPG may be a useful indicator of the severity and stage of these cancers.

MPG is also a target for researchers studying the mechanisms of cancer development. By inhibiting DNA replication, MPG can be used to study how changes in DNA replication patterns can contribute to the development of cancer. This information can be used to develop new treatments and improve our understanding of the underlying causes of cancer.

Overall, MPG is a promising drug target and biomarker for cancer. Its ability to inhibit DNA replication makes it an attractive target for treatments that aim to prevent the growth and spread of cancer cells. Additionally, its potential as a biomarker for cancer makes it an important tool for researchers studying the mechanisms of cancer development. Further research is needed to fully understand the potential of MPG as a drug target and biomarker for cancer.

Protein Name: N-methylpurine DNA Glycosylase

Functions: Hydrolysis of the deoxyribose N-glycosidic bond to excise 3-methyladenine, and 7-methylguanine from the damaged DNA polymer formed by alkylation lesions

The "MPG Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MPG comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets